JIRAVSKÝ, Otakar, Radim ŠPAČEK, Jan CHOVANČÍK, Radek NEUWIRTH, Miroslav HUDEC, Libor ŠKŇOUŘIL, Radka ŠTĚPÁNOVÁ, Paulina SUCHACKOVA, Jan HECKO, Martin FIALA and Roman MIKLÍK. Early ganglion stellate blockade as part of two-step treatment algorithm suppresses electrical storm and need for intubation. HELLENIC JOURNAL OF CARDIOLOGY. AMSTERDAM: ELSEVIERRADARWEG, 2023, vol. 73, September-October 2023, p. 24-35. ISSN 1109-9666. Available from: https://dx.doi.org/10.1016/j.hjc.2023.04.003.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Early ganglion stellate blockade as part of two-step treatment algorithm suppresses electrical storm and need for intubation
Authors JIRAVSKÝ, Otakar (203 Czech Republic, belonging to the institution), Radim ŠPAČEK (203 Czech Republic), Jan CHOVANČÍK (203 Czech Republic), Radek NEUWIRTH (203 Czech Republic, belonging to the institution), Miroslav HUDEC (203 Czech Republic, belonging to the institution), Libor ŠKŇOUŘIL (203 Czech Republic), Radka ŠTĚPÁNOVÁ (203 Czech Republic, belonging to the institution), Paulina SUCHACKOVA, Jan HECKO (203 Czech Republic), Martin FIALA (203 Czech Republic, belonging to the institution) and Roman MIKLÍK (203 Czech Republic, guarantor).
Edition HELLENIC JOURNAL OF CARDIOLOGY, AMSTERDAM, ELSEVIERRADARWEG, 2023, 1109-9666.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.100 in 2022
RIV identification code RIV/00216224:14110/23:00131355
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.hjc.2023.04.003
UT WoS 001083682800001
Keywords in English Stellate ganglion blockade; Electrical storm; ICD therapy; Ventricular arrhythmia; Neuromodulation
Tags 14110211, 14110516, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 12/1/2024 12:36.
Abstract
Background: For the treatment of patients with electrical storm (ES), we established a two-step algorithm comprising standard anti-arrhythmic measures and early ultrasound-guided stellate ganglion blockade (SGB). In this single-center study, we evaluated the short-term efficacy of the algorithm and tested the hypothesis that early SGB might prevent the need for intubations.Methods: Overall, we analyzed data for 70 ES events in 59 patients requiring SGB (mean age 67.7 +/- 12.4 years, 80% males, left ventricular ejection fraction 30.0% +/- 9.1%), all with implantable cardioverter-defibrillators (ICDs).Results: The mean time from ES onset to SGB was 13.2 +/- 12.3 hours. Percentage and mean absolute reduction in shocks at 48 hours after SGB reached 86.8% (-6.3 shocks), and anti-tachycardiac pacing (ATP) declined by 65.9% (-51.1 ATPs; all P < 0.001). Patients with the highest sustained ventricular arrhythmia (VA) burden (shocks >= 10/48 h; ATPs 10-99/48 h and >= 100/48 h) experienced the highest percentage decrease in ICD therapy (shocks -99.1%; ATPs-92.1% and -10 0.0%, respectively). For clinical response by defined criteria and two outcome periods (1/no sustained VA <= 48 hours post SGB, and 2/no ICD shock or <3 ATPs/day from day 3 to discharge/catheter ablation/day 8), 75.7% and 76.1% experienced complete response, respectively. Catecholamine support, no/low-dose beta-blocker therapy, polymorphic/ mixed-type VA, and baseline sinus rhythm versus atrial fibrillation were more frequent in patients with early arrhythmia recurrence. Temporary Horner's syndrome occurred in 67.1%, and no other adverse events were recorded. Intubation and general anesthesia during and after SGB were not needed.Conclusion: The presented two-step algorithm for treating ES proved efficacious and safe. The results support implementation of early SGB in routine ES management.(c) 2023 Hellenic Society of Cardiology.
Links
CZ.02.1.01/0.0/0.0/16_013/0001826, interní kód MU
(CEP code: EF16_013/0001826)
Name: CZECRIN_PRO PACIENTY - zavádění inovativních moderních terapií
Investor: Ministry of Education, Youth and Sports of the CR, Priority axis 1: Strengthening capacities for high-quality research
90249, large research infrastructuresName: CZECRIN IV
PrintDisplayed: 17/7/2024 06:35